Deregulation of apolipoprotein C2 gene in cancer: A potential metabolic vulnerability
Main Authors: | Yuqiao Liu, Yiting Meng, Tian Zhang, Houda Alachkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.406 |
Similar Items
-
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
by: Oliviero Olivieri, et al.
Published: (2003-12-01) -
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01) -
Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer
by: Shi X, et al.
Published: (2020-12-01) -
Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling
by: Hao Jiang, et al.
Published: (2021-01-01) -
Effects of albumin and apolipoprotein C-II on the acyl-chain specificity of lipoprotein lipase catalysis.
by: Chi-Sun Wang, et al.
Published: (1993-12-01)